ImmunityBio (IBRX) Intangibles (2014 - 2024)

ImmunityBio (IBRX) has 10 years of Intangibles data on file, last reported at $16.1 million in Q2 2024.

• On a quarterly basis, Intangibles fell 15.45% year-over-year to $16.1 million in Q2 2024; TTM through Jun 2024 was $16.1 million, a 15.45% decrease from a year earlier, with the FY2023 full-year figure at $17.1 million, down 14.55% from the prior year.
• Intangibles for Q2 2024 stood at $16.1 million, down from $16.6 million in the prior quarter.
• Over the last five years, Intangibles for IBRX reached as high as $22.3 million in Q1 2022 and fell as low as $1.4 million in Q4 2021.
• Historically, Intangibles has averaged $13.2 million across 5 years, with a median of $17.1 million in 2023.
• Across the five-year window, Intangibles surged 1454.17% in 2022 and dropped 15.45% in 2024, its largest moves.
• Year by year, Intangibles stood at $1.5 million in 2020, then declined by 2.94% to $1.4 million in 2021, then jumped by 1308.66% to $20.0 million in 2022, then retreated by 14.55% to $17.1 million in 2023, then fell by 6.06% to $16.1 million in 2024.
• Per Business Quant data, the three most recent Intangibles figures were $16.1 million in Q2 2024, $16.6 million in Q1 2024, and $17.1 million in Q4 2023.